Novartis, Genentech Again Beat Xolair Kickback Suit
Whistleblowers accusing Novartis Pharmaceuticals Corp. and Genentech Inc. of paying physicians kickbacks to boost prescriptions for the asthma medication Xolair had their suit dismissed a second time Tuesday, with a New...To view the full article, register now.
Already a subscriber? Click here to view full article